XML 21 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
May 31, 2023
May 31, 2022
May 31, 2021
Cash Flows From Operating Activities:      
Net Income $ 479,731,000 $ 492,466,000 $ 503,500,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 154,949,000 153,074,000 146,857,000
Restructuring charges, net of payments   (2,516,000) (2,909,000)
Goodwill impairment 36,745,000 0 0
Fair value adjustments to contingent earnout obligations   3,253,000 (582,000)
Deferred income taxes 6,236,000 (25,067,000) 20,188,000
Stock-based compensation expense 28,673,000 40,114,000 40,926,000
Net loss (gain) on marketable securities 2,086,000 17,706,000 (38,774,000)
Net (gain) on sales of assets and a business (28,632,000) (51,983,000)  
Other 1,683,000 (66,000) (2,340,000)
Changes in assets and liabilities, net of effect from purchases and sales of businesses:      
(Increase) in receivables (94,585,000) (187,299,000) (88,618,000)
Decrease (increase) in inventory 66,805,000 (304,197,000) (68,802,000)
Decrease (increase) in prepaid expenses and other current and long-term assets 1,364,000 (13,040,000) (11,457,000)
(Decrease) increase in accounts payable (116,053,000) 101,223,000 151,388,000
(Decrease) increase in accrued compensation and benefits (2,643,000) 9,737,000 62,966,000
Increase (decrease) in accrued losses 2,231,000 (3,956,000) 8,510,000
Increase (decrease) in other accrued liabilities 38,515,000 (50,718,000) 43,010,000
Other     2,293,000
Cash Provided By Operating Activities 577,105,000 178,731,000 766,156,000
Cash Flows From Investing Activities:      
Capital expenditures (254,435,000) (222,403,000) (157,199,000)
Acquisition of businesses, net of cash acquired (47,542,000) (127,457,000) (165,223,000)
Purchase of marketable securities (18,674,000) (15,032,000) (121,669,000)
Proceeds from sales of marketable securities 12,731,000 21,533,000 112,298,000
Proceeds from sales of assets and a business 58,288,000 76,590,000  
Other (72,000) 7,222,000 5,405,000
Cash (Used For) Investing Activities (249,704,000) (259,547,000) (326,388,000)
Cash Flows From Financing Activities:      
Additions to long-term and short-term debt 341,720,000 437,564,000  
Reductions of long-term and short-term debt (355,463,000) (101,505,000) (188,278,000)
Cash dividends (213,912,000) (204,394,000) (194,720,000)
Repurchase of common stock (50,000,000) (52,500,000) (49,956,000)
Shares of common stock returned for taxes (17,047,000) (11,549,000) (22,826,000)
Payments of acquisition-related contingent consideration (3,765,000) (5,774,000) (2,218,000)
Other (2,689,000) (4,452,000) (1,621,000)
Cash (Used For) Provided By Financing Activities (301,156,000) 57,390,000 (459,619,000)
Effect of Exchange Rate Changes on Cash and Cash Equivalents (12,130,000) (21,606,000) 33,139,000
Net Change in Cash and Cash Equivalents 14,115,000 (45,032,000) 13,288,000
Cash and Cash Equivalents at Beginning of Period 201,672,000 246,704,000 233,416,000
Cash and Cash Equivalents at End of Period 215,787,000 201,672,000 246,704,000
Cash paid during the year for:      
Interest 113,953,000 81,838,000 82,440,000
Income taxes, net of refunds 134,436,000 172,254,000 147,436,000
Supplemental Disclosures of Non-Cash Investing and Financing Activities:      
Capital expenditures accrued within accounts payable at year-end $ 34,470,000 $ 27,237,000 $ 29,848,000